IMVT

IMVT Operating Expenses

$566.00MTTM · USD

Period ending:

IMVT FY Operating ExpensesUSD
IMVT FY Operating Expenses2018-03-31: $136.74M2019-03-31: $448.002020-03-31: $59.66M2021-03-31: $108.12M2022-03-31: $156.03M2023-03-31: $208.28M2024-03-31: $270.21M2025-03-31: $438.15M2026-03-31: $532.90M$532.90M$0.00
2018-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IMVT operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 9 observations from Mar 31, 2018 to Mar 31, 2026.

Immunovant Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
532,902,000
438,152,000
270,209,000
208,276,000
156,033,000
108,117,000
59,657,000
448
136,740,000

Compare operating expenses

All IMVT financial metrics · IMVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.